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Heraclitus was not known as the ‘obscure philoso-
pher’ without reason. We may not step into the same
river twice but it will be a very similar river in the
future (salmon – not native to Greece and so perhaps
unfamiliar to Heraclitus – have no difficulty returning
to the ‘same’ river 4 years later). Are epidemiologists
to abandon all calculations of attributable risk or all
attempts at prediction because the actual index popu-
lation no longer exists? What is the point of ran-
domised trials or, indeed, any research for that matter,
if we cannot make assumptions that the population
studied is rather similar to the population in which
the results of the research will be applied?1
The US pregnant population is extremely heteroge-
neous, and while it may be that true representative-
ness will never be achieved in the National Children’s
Study (NCS), even with a valid representative sam-
pling plan, starting out with a population sampling
design will surely result in a sample that is much
more representative than if a convenience sample is
initiated. Moreover, as described in our initial paper,2
population-based sampling within the context of a
well-defined multistage random sampling design will
permit the use of weights that correct for underpar-
ticipation, thereby allowing analyses to have external
validity. Why even bother with a ‘national’ children’s
study if not to have the capacity to draw conclusions
applicable beyond the enrolees who are de facto distin-
guished from non-participants by their interest and
commitment to research as well as sociodemographic
and other characteristics? In addition to being able to
accurately estimate prevalence and attributable risk,
having a probability sample helps ensure that associa-
tions are more validly estimated, for example, avoid-
ing bias due to inadvertently over- or under-selecting
high or low exposed children differentially by disease
status.
Even with an NCS total sample of 100 000, stratifi-
cation into groups of particular interest is likely to
substantially reduce the power to test hypotheses in
some subpopulations at particular risk: the unders-
erved, those without any prenatal care and minority
populations. Convenience sampling is especially
likely to underrepresent these groups. However, a
population-based sample, which enhances the inten-
sity of recruitment strategies in these populations, will
improve the chances of more balanced final sample
sizes in these groups. Indeed, ‘health disparities’ is
one area of study mandated by the Children’s Health
Act of 2000 that led to the NCS. Populations deprived
of health care access, health information, healthy diets
and other amenities enjoyed by more privileged
sectors of the population must be adequately repre-
sented to undertake valid research on disparities.
Options to obtain ‘supplemental’ samples of unders-
erved populations currently being considered by the
NCS leadership are entirely inadequate. They would
be obtained from different populations and using pro-
cedures incomparable to the majority groups enrolled
through the primary recruitment strategy.
There is no evidence that recruiting a probability
sample is any more expensive in money or time than
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non-representative strategies. Posing internal and
external validity as being at odds with each other is a
curious twist: in what way does population-based
sampling for a large cohort detract from internal
validity? For that matter, how is probability sampling
less ethical than convenience sampling? On the other
hand, embarking on a study that is destined to be
unable to answer some of the major questions con-
cerning pregnancy and disease in underserved popu-
lations strikes us as being highly irresponsible.
If high impact rare diseases (such as autism) and
complex childhood disorders (for example, Type 1
and increasingly Type 2 diabetes) are to be studied
within the NCS, it cannot be left entirely to chance
that sufficient cases are sampled. Similarly, rare expo-
sures can only be studied with some degree of preci-
sion in a sample that captures the broad range of
environmental agents to which US women, and their
fetuses and children, are exposed. This includes as yet
unknown and unanticipated exposures which may
become of future interest.
The Danes are fortunate in having several linked
complete population registries which Professor Olsen
and many colleagues have used to great advantage in
studying reproductive and perinatal health. Fortu-
nately for them, sampling was not necessary. Among
the many benefits of reasonably complete national
registries is the capacity to contrast participants from
non-participants and to adjust for these in statistical
analyses and to recognise any resulting limitations to
external validity from the enrolled subjects. But
national registries of this type in the US are a pipe
dream and the closest that will be achieved are
population-based samples. In the absence of probabil-
ity sampling, the scientific utility of the NCS will be a
fraction of its full potential. It is no coincidence that
each of the many advisory groups and panels of sam-
pling experts to have considered the NCS study
design has without exception endorsed probability
sampling,3,4 including a major review by the Institute
of Medicine.5
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